DANVILLE, Calif.--(BUSINESS WIRE)--VasoStitch announced today the establishment of its Scientific Advisory Board with the appointment of Willam Fearon, M.D., and Prof. Chaim Lotan, M.D., as its first members.
Current surgical arterial or cardiac access and closure for large-diameter, catheter-based intervention such as TAVR (transcatheter aortic valve replacement) adds up to an hour to an already long, complex procedure. A device that can replicate the current ‘gold standard’ of surgical access-and-closure in a more rapid and facile fashion would reduce healthcare costs dramatically, enhance adoption of large diameter cardiovascular and endovascular therapies, and improve the efficiency of patient management.
